Effect of Sarcopenia on Swallowing in Patients With Head and Neck Cancer
Otolaryngology–Head and Neck Surgery · 2024-05 · 170 (5) · 1331-1337
DOI: 10.1002/ohn.655 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 05.02.2024. Verfasst von Angela A Colback und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of California, Davis, Sacramento, California, USA. Hauptthemen laut MEDLINE: Sarcopenia, Deglutition Disorders, Head and Neck Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Objective
Sarcopenia, characterized by decreased skeletal muscle mass, is associated with poorer oncologic outcomes in head and neck cancer (HNC) patients. The effect of sarcopenia on swallowing following HNC treatment is unknown. This study aims to investigate the association of sarcopenia and swallowing dysfunction in patients treated for HNC. Study Design Retrospective cohort study.
Setting
Academic medical center.
Methods
Pretreatment sarcopenia was assessed using the skeletal muscle index calculated from cross‐sectional imaging at the third cervical vertebra. Feeding tube dependence, patient‐reported dysphagia, and swallowing safety were assessed before and after treatment with the Functional Oral Intake Scale, Eating Assessment Tool‐10, and Penetration Aspiration Scale, respectively. The association between sarcopenia and swallowing dysfunction was evaluated.
Results
A total of 112 patients were included, 84 males (75%) and 28 females (25%). A total of 69 (61.6%) had sarcopenia prior to initiating HNC therapy. Sarcopenia was significantly associated with an elevated risk of patient‐reported dysphagia (odds ratio [OR] = 2.71 [95% confidence interval, CI, 1.12‐6.79]; P < .05). Multivariate logistic regression demonstrated that sarcopenia (OR = 15.18 [95% CI, 1.50‐453.53]; P < .05) is an independent predictor for aspiration following treatment for HNC.
Conclusion
Patients with pretreatment sarcopenia had higher rates of dysphagia before treatment and were more likely to develop aspiration after completion of HNC therapy. Sarcopenia is readily measured using cross‐sectional imaging and may be useful for identifying patients at risk of swallowing dysfunction and those most likely to benefit from prehabilitation efforts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of California, Davis, Sacramento, California, USA.
- Department of Radiology, Division of Neuroradiology, University of California, Davis, Sacramento, California, USA.
ORCID-Profile: Daniel J Cates
Zitieren
APA
Colback, A. A., Arkfeld, D. V., Evangelista, L. M., Paydar, A., Raslan, O., Abouyared, M., & Cates, D. J. (2024). Effect of Sarcopenia on Swallowing in Patients With Head and Neck Cancer. Otolaryngology–Head and Neck Surgery, 170(5), 1331-1337. https://doi.org/10.1002/ohn.655
Vancouver
Colback AA, Arkfeld DV, Evangelista LM, Paydar A, Raslan O, Abouyared M, et al. Effect of Sarcopenia on Swallowing in Patients With Head and Neck Cancer. Otolaryngology–Head and Neck Surgery. 2024;170(5):1331-1337. doi:10.1002/ohn.655
BibTeX
@article{Colback2024,
author = {Colback, Angela A and Arkfeld, Daniel V and Evangelista, Lisa M and Paydar, Alireza and Raslan, Osama and Abouyared, Marianne and Cates, Daniel J},
title = {Effect of Sarcopenia on Swallowing in Patients With Head and Neck Cancer},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2024},
volume = {170},
number = {5},
pages = {1331--1337},
doi = {10.1002/ohn.655}
}
EUVIMED